TET2 and melanoma: A cohort of primary melanoma samples from 14 patients were examined using cyclic immunofluorescence (CyCIF) imaging and antibodies against SOX10 (melanocytes), CK14 and panCK (epidermal keratinocytes), PRAME, TET2 and 5-hmC (52–54).